S. 4351 · 117th Congress
Enhanced Access to Affordable Medicines Act of 2022
- Stage
- In committee
- Sponsor
- Mitt Romney
- Introduced
- 2022-06-06
- Latest action
- 2022-06-06 · Introduced in Senate
Summary
Enhanced Access to Affordable Medicines Act of 2022
This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, a revised label for the brand-name drug is approved within 90 days of when the generic is otherwise eligible for approval.